Merus annonce ses résultats financiers pour le deuxième trimestre 2024 et fait le point sur ses activités
August 03, 2024 12:36 ET
|
Merus N.V.
- Données provisoires de l’association pétosemtamab + pembrolizumab présentées lors de l’édition 2024 du congrès de l’ASCO®, avec démonstration d’un taux de réponse solide de 67 % chez 24 patients...
Merus gibt die Finanzergebnisse für das zweite Quartal 2024 bekannt und informiert über den aktuellen Geschäftsverlauf
August 03, 2024 12:36 ET
|
Merus N.V.
– Zwischenergebnisse zu Petosemtamab in Kombination mit Pembrolizumab, die auf der ASCO® 2024 präsentiert wurden, zeigten eine robuste Ansprechrate von 67 % bei 24 auswertbaren Patienten – Erste...
Lavoro Announces New R$310 Million 3-Year FIDC-Fiagro Credit Facility
August 02, 2024 20:15 ET
|
Lavoro Limited
SÃO PAULO, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Lavoro Limited (Nasdaq: LVRO), the first U.S.-listed pure-play agricultural inputs retailer in Latin America, today announced the establishment of a...
Microchip Technology to Present at the KeyBanc Capital Markets Technology Leadership Forum
August 02, 2024 19:30 ET
|
Microchip Technology Inc.
CHANDLER, Ariz., Aug. 02, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced...
Lotus Technology to Report Unaudited First Half 2024 Financial Results on August 28, 2024
August 02, 2024 19:00 ET
|
Lotus Technology Inc.
NEW YORK , Aug. 02, 2024 (GLOBE NEWSWIRE) -- Lotus Technology Inc. (“Lotus Tech” or the “Company”) (Nasdaq: LOT), a leading global luxury electric vehicle maker, today announced that it will report...
Maquia Capital Acquisition Corporation Plans to Trade OTC After Delist from Nasdaq
August 02, 2024 18:35 ET
|
Maquia Capital Acquisition Corporation
Miami, Florida, Aug. 02, 2024 (GLOBE NEWSWIRE) -- On May 7, 2024, Maquia Capital Acquisition Corporation (“Maquia” or the “Company”) received a notice from the Listing Qualifications Department of...
FDA Advisory Committee Votes Favorably that the Data Support Arimoclomol as Effective Treatment for Patients with Niemann-Pick Disease Type C
August 02, 2024 17:50 ET
|
Zevra Therapeutics
CELEBRATION, Fla., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a rare disease therapeutics company, today announced that the U.S. Food and...
Talen Statement on FERC’s Issuance of a Deficiency Letter Regarding Susquehanna ISA and New Generic Proceeding Initiating a Commissioner-led Technical Conference
August 02, 2024 17:46 ET
|
Talen Energy Corporation
HOUSTON, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Talen Energy Corporation ("Talen") (NASDAQ: TLN) issued the following statements in response to the Federal Energy Regulatory Commission (the “FERC”) today...
Helport AI Limited and Tristar Acquisition I Corp. Announce Closing on Reduced $5.5 Million PIPE Investment Concurrently with Closing of Business Combination
August 02, 2024 17:07 ET
|
Helport AI Limited
SINGAPORE and BURLINGTON, Mass., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Helport AI Limited (together with its operating subsidiaries, “Helport”), an AI technology company serving enterprises’ customer...
JOYY Announces Leadership Transition
August 02, 2024 17:00 ET
|
JOYY Inc.
SINGAPORE, Aug. 03, 2024 (GLOBE NEWSWIRE) -- JOYY Inc. (Nasdaq: YY) (“JOYY” or the “Company”), a global technology company, today announced that its board of directors (the “Board”) has approved a...